About
Hyperpolarized gases for MRI
Areas of Focus
Categories
Medical Imaging TechnologyNorth & South Carolina
Team (11)
Alex Dusek
Chief Commercial Officer
Polarean Imaging
team_member
Bastiaan Driehuys, PhD
Founder and Chief Scientific Officer
Polarean Imaging
executivefounder
Christopher von Jako, PhD
Chief Executive Officer
Polarean Imaging
executive
Chuck Osborne
Chief Financial Officer
Polarean Imaging
executive
Cyrille Petit
Non-Executive Director
Polarean Imaging
team_member
Daniel Brague
Non-Executive Director
Polarean Imaging
team_member
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
102
By Phase
PHASE1: 1PHASE3: 2
By Status
RECRUITING: 2COMPLETED: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07139899Collaborator
Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma
N/ANot yet recruiting
5 participants
Started: Nov 1, 2025 · Completed: Sep 30, 2027
NCT06985225Collaborator
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma
N/ARecruiting
5 participants
Started: Jun 30, 2025 · Completed: Dec 31, 2026
NCT06271408Lead Sponsor
Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging
PHASE1Recruiting
6 participants
Started: Feb 29, 2024 · Completed: Apr 30, 2024
NCT03417687Lead Sponsor
Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection
PHASE3Completed
38 participants
Started: Aug 17, 2018 · Completed: Mar 10, 2020
NCT03418090Lead Sponsor
Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant
PHASE3Completed
48 participants
Started: Aug 17, 2018 · Completed: Nov 4, 2019
Locations (1)
Headquarters
Durham, NC, United States
Map
Loading map...